Zepbound Outperforms Wegovy in Weight Loss Trial

By Rene Pretorius

December 6, 2024

The news release from Eli Lilly and Company, titled "Lilly's Zepbound® (tirzepatide) superior to Wegovy® (se...
Dark Chocolate: A Sweet Ally Against Type 2 Diabetes and More
Improving Cervical Cancer Screening: HPV Self-Collection Tests
Overview of NICE’s Elranatamab Managed Access Agreement
HARMONi-2 Trial Results Transforming NSCLC
KEYTRUDA Head Neck Cancer Phase 3 Trial
UNAIDS Urges Greater Access for Gilead’s Lenacapavir
FDA Approves Inavolisib Breast Cancer Treatment
Enhancing Mental Health Care for Youth: A Critical Need
FDA’s Opdivo Lung Cancer Approval
Enhancing Global Health through Regulatory Collaboration
Mental Health Trends Among US Youths: Rising Prevalence of Depression and Anx...
Created and Validated by FDA: AI Drug Safety Surveillance Tool